Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Data Brief ; 14: 77-83, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28795085

RESUMEN

Natural Killer (NK) cells mediate innate immunity against cancer and intracellular infection, at that, operating in often oxygen-deprived environments. We performed a microarray experiment with a 2×2 factorial design to profile gene expression in human NK cells (Velasquez et al., 2016) [1]. In this experiment, NK cells from 5 healthy volunteers were primed or not for 6 h with the survival factor and inflammatory cytokine interleukin 15 (IL-15) under hypoxic or normoxic culture conditions (20 samples in total). Here, we provide details on the culture setup that govern the actual O2 partial pressure (pO2) experienced by the cells, as well as on the RNA extraction procedure used, which we optimized from commercial spin column protocols to obtain highly concentrated total RNA. We present a quality control analysis of the normalized microarray data, as well as overviews for differentially regulated genes. These data provide insights into NK cell transcriptional responses to immune stimulation under physiologically relevant low oxygen conditions. This dataset is deposited in the Gene Expression Omnibus database (accession number GSE70214).

2.
Biol Blood Marrow Transplant ; 23(2): 247-254, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27816649

RESUMEN

An intra-bone marrow (IBM) hematopoietic stem cell transplantation (HSCT) is assumed to optimize the homing process and therefore to improve engraftment as well as hematopoietic recovery compared with conventional i.v. HSCT. This study investigated the feasibility and efficacy of IBM HSCT after nonmyeloablative conditioning in an allogeneic canine HSCT model. Two study cohorts received IBM HSCT of either density gradient (IBM-I, n = 7) or buffy coat (IBM-II, n = 6) enriched bone marrow cells. An historical i.v. HSCT cohort served as control. Before allogeneic HSCT experiments were performed, we investigated the feasibility of IBM HSCT by using technetium-99m marked autologous grafts. Scintigraphic analyses confirmed that most IBM-injected autologous cells remained at the injection sites, independent of the applied volume. In addition, cell migration to other bones occurred. The enrichment process led to different allogeneic graft volumes (IBM-I, 2 × 5 mL; IBM-II, 2 × 25 mL) and significantly lower counts of total nucleated cells in IBM-I grafts compared with IBM-II grafts (1.6 × 108/kg versus 3.8 × 108/kg). After allogeneic HSCT, dogs of the IBM-I group showed a delayed engraftment with lower levels of donor chimerism when compared with IBM-II or to i.v. HSCT. Dogs of the IBM-II group tended to reveal slightly faster early leukocyte engraftment kinetics than intravenously transplanted animals. However, thrombocytopenia was significantly prolonged in both IBM groups when compared with i.v. HSCT. In conclusion, IBM HSCT is feasible in a nonmyeloablative HSCT setting but failed to significantly improve engraftment kinetics and hematopoietic recovery in comparison with conventional i.v. HSCT.


Asunto(s)
Trasplante de Médula Ósea/métodos , Antígenos de Histocompatibilidad Clase I/inmunología , Aloinjertos , Animales , Autoinjertos , Movimiento Celular , Perros , Supervivencia de Injerto , Histocompatibilidad , Infusiones Intraóseas , Infusiones Intravenosas , Masculino , Acondicionamiento Pretrasplante
3.
J Biol Chem ; 291(25): 12960-77, 2016 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-27129235

RESUMEN

Natural killer (NK) cells induce apoptosis in infected and transformed cells and are important producers of immunoregulatory cytokines. Therefore, they operate under low oxygen conditions (hypoxia) in inflammatory and tumor environments. In vitro studies of NK cells are, however, commonly performed in ambient air (normoxia). We used global gene expression profiling to evaluate changes in transcriptional pathways in primary human NK cells following short term culture under hypoxia compared with normoxia and in response to interleukin 15 (IL-15) priming using a 2 × 2 factorial design. The largest contrasts observed were priming dependences for associations between hypoxia and the hypoxia-inducible factor (Hif) 1 signaling and glycolysis pathways. RT-PCR confirmed positive synergistic hypoxia/IL-15 interactions for genes of key regulatory and metabolic enzymes. IL-15 primes NK cells for effector functions, which were recently demonstrated to depend on glycolytic switching. We did not, however, observe important increases in glycolytic flux through hypoxia and priming alone. Chemical Hif-1α inhibition suggested equal importance of this transcription factor for glycolysis and energy production under normoxia and hypoxia. Hypoxia promoted secretion of CC chemokines Ccl3/4/5 and macrophage migration inhibitory factor. Unexpectedly, hypoxia also stimulated migration of NK cells through the extracellular matrix and shifted amounts of susceptible leukemia target cells toward late apoptosis in a cell killing assay. We conclude that short term hypoxia supports these activities by positively interacting with NK cell priming at the level of glycolytic gene transcription. Hypoxic conditioning of NK cells may thus benefit their use in cell-based immunotherapy of cancer.


Asunto(s)
Glucólisis/genética , Interleucina-15/fisiología , Células Asesinas Naturales/metabolismo , Transcripción Genética , Adenosina Trifosfato/metabolismo , Traslado Adoptivo , Apoptosis , Hipoxia de la Célula , Movimiento Celular , Supervivencia Celular , Quimiocinas/metabolismo , Humanos , Factor 1 Inducible por Hipoxia/metabolismo , Células K562 , L-Lactato Deshidrogenasa/metabolismo , Transducción de Señal , Activación Transcripcional
4.
Biol Blood Marrow Transplant ; 22(4): 637-643, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26802322

RESUMEN

The canine hematopoietic stem cell transplantation (HSCT) model has become accepted in recent decades as a good preclinical model for the development of new transplantation strategies. Information on factors associated with outcome after allogeneic HSCT are a prerequisite for designing new risk-adapted transplantation protocols. Here we report a retrospective analysis aimed at identifying risk factors for allograft rejection in the canine HSCT model. A total of 75 dog leukocyte antigen-identical sibling HSCTs were performed since 2003 on 10 different protocols. Conditioning consisted of total body irradiation at 1.0 Gy (n = 20), 2.0 Gy (n = 40), or 4.5 Gy (n = 15). Bone marrow was infused either intravenously (n = 54) or intraosseously (n = 21). Cyclosporin A alone or different combinations of cyclosporine A, mycophenolate mofetil, and everolimus were used for immunosuppression. A median cell dose of 3.5 (range, 1.0 to 11.8) total nucleated cells (TNCs)/kg was infused. Cox analyses were used to assess the influence of age, weight, radiation dose, donor/recipient sex, type of immunosuppression, and cell dose (TNCs, CD34(+) cells) on allograft rejection. Initial engraftment occurred in all dogs. Forty-two dogs (56%) experienced graft rejection at median of 11 weeks (range, 6 to 56 weeks) after HSCT. Univariate analyses revealed radiation dose, type of immunosuppression, TNC dose, recipient weight, and recipient age as factors influencing long-term engraftment. In multivariate analysis, low radiation dose (P < .001) and low TNC cell count (P = .044) were identified as significant independent risk factors for graft rejection. Peripheral blood mononuclear cell chimerism ≥30% (P = .008) and granulocyte chimerism ≥70% (P = .023) at 4 weeks after HSCT were independent predictors of stable engraftment. In summary, these data indicate that even in low-dose total body irradiation-based regimens, the irradiation dose is important for engraftment. The level of blood chimerism at 4 weeks post-HSCT was predictive of long-term engraftment in the canine HSCT model.


Asunto(s)
Células de la Médula Ósea/efectos de la radiación , Trasplante de Médula Ósea/métodos , Rayos gamma/uso terapéutico , Rechazo de Injerto/inmunología , Enfermedad Injerto contra Huésped/inmunología , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/inmunología , Trasplante de Médula Ósea/efectos adversos , Recuento de Células , Ciclosporina/farmacología , Perros , Relación Dosis-Respuesta en la Radiación , Everolimus/farmacología , Femenino , Rechazo de Injerto/patología , Supervivencia de Injerto , Enfermedad Injerto contra Huésped/patología , Enfermedad Injerto contra Huésped/prevención & control , Antígenos HLA/genética , Antígenos HLA/inmunología , Inmunosupresores/farmacología , Masculino , Modelos Animales , Ácido Micofenólico/farmacología , Estudios Retrospectivos , Factores de Riesgo , Quimera por Trasplante , Acondicionamiento Pretrasplante , Trasplante Homólogo , Irradiación Corporal Total
5.
J Biophotonics ; 8(8): 646-58, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25302483

RESUMEN

Gold nanoparticle mediated (GNOME) laser transfection is a powerful technique to deliver small biologically relevant molecules into cells. However, the transfection of larger and especially negatively charged DNA remains challenging. The efficiency for pDNA was 0.57% using parameter that does not influence the endo- and exogenous DNA. In order to gain a deeper understanding of the actual molecule uptake process, the uptake efficiency was determined using molecules of different sizes. It was evaluated that uncharged dextran molecules (2000 kDa) were delivered with an efficiency of 68%. The intracellular distribution of injected molecules was visualized and larger molecules were primary found in the cytoplasm. Patch clamp measurements suggested a permeabilization time up to 15 minutes. The uptake efficiency depended on the size and charge of the molecule to deliver as well as the cell size. A minor role for transfection plays the cell type since primary stem cells were successfully transfected. The perforation efficiency of semi-adherent and suspension cells is influenced by the cell and molecule size.


Asunto(s)
Fenómenos Biofísicos , Oro/química , Rayos Láser , Nanopartículas del Metal/química , Células Madre/metabolismo , Transfección/métodos , Animales , Línea Celular Tumoral , Permeabilidad de la Membrana Celular , Tamaño de la Célula , ADN/genética , ADN/metabolismo , Perros
6.
Biol Blood Marrow Transplant ; 20(9): 1301-6, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24923538

RESUMEN

The mammalian target of rapamycin inhibitor everolimus (RAD001) is a successfully used immunosuppressant in solid-organ transplantation. Several studies have already used RAD001 in combination with calcineurin inhibitors after hematopoietic stem cell transplantation (HSCT). We investigated calcineurin inhibitor-free pre- and post-transplantation immunosuppression of RAD001 combined with mycophenolate mofetil (MMF) in a nonmyeloablative HSCT setting. After nonmyeloablative conditioning with 2 Gy total body irradiation, 8 dogs received HSCT from dog leukocyte antigen-identical siblings. Immunosuppressives were given at doses of 1.5 mg RAD001 twice daily from day -1 to +49, then tapered until day +56, and 20 mg/kg MMF from day 0 to +28, then tapered until day +42. An historical cyclosporin A (CsA)/MMF regimen was used in the control group. All dogs engrafted. Median platelet nadir amounted in all dogs to 0 × 10(9)/L (median, day +10; duration <50 × 10(9)/L, 22 days) and median leukocyte nadir was 1.0 × 10(9)/L (range, .1 to 2.5 × 10(9)/L; median, day +13). Eventually, 5 of 8 (63%) animals rejected their grafts. Two dogs died of infections on day +19 and +25. Pharmacokinetics of RAD001 and MMF showed median trough levels of 19.1 (range, 10.5 to 43.2) µg/L and .3 (.1 to 1.3) mg/L, respectively. The median area under the curve was 325 (range, 178 to 593) µg/L × hour for RAD001 and 29.6 (range, 7.9 to 40.5) ng/L × hour for MMF. All dogs developed clinically mucosal viral infections during the clinical course. Compared with the control group, the level of toxicities for RAD001/MMF increased in all qualities. Combined immunosuppression of RAD001 and MMF after nonmyeloablative HSCT is associated with significant toxicities, including a prolonged platelet recovery time as well as increased infections compared to the CsA/MMF regimen.


Asunto(s)
Terapia Combinada/métodos , Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Sirolimus/análogos & derivados , Animales , Quimerismo , Perros , Everolimus , Trasplante de Células Madre Hematopoyéticas , Terapia de Inmunosupresión , Inmunosupresores/administración & dosificación , Inmunosupresores/farmacocinética , Ácido Micofenólico/administración & dosificación , Ácido Micofenólico/farmacocinética , Ácido Micofenólico/uso terapéutico , Sirolimus/administración & dosificación , Sirolimus/farmacocinética , Sirolimus/uso terapéutico
7.
In Vivo ; 27(6): 761-71, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24292580

RESUMEN

BACKGROUND/AIM: Dendritic cells (DCs) are important immune mediators following allogeneic hematopoietic stem cell transplantation (HSCT). We screened for DC frequency in the cornea and oral mucous membranes after HSCT by confocal laser scanning microscopy (CLSM) in a canine model. MATERIALS AND METHODS: In vivo CLSM images of the epithelia were taken the day before and on days 28, 56 and 112 following HSCT. Peripheral blood counts and chimerism were determined. RESULTS: An increase of DCs after HSCT was detected in each animal in both investigated tissue types. Highest DC numbers in the flew and the gingiva were detected on day 28 and in the corneal epithelium on day 56 after HSCT, respectively. CONCLUSION: Changes of DCs in ocular and non-ocular mucous membranes can be monitored by CLSM in vivo. The DC frequency in the cornea and mucosa changes following HSCT. DC recovery is rapid and their numbers correlate with the development of chimerism of peripheral blood mononuclear cells.


Asunto(s)
Células Dendríticas/inmunología , Epitelio Corneal/citología , Trasplante de Células Madre Hematopoyéticas , Mucosa Bucal/citología , Animales , Recuento de Células , Perros , Microscopía Confocal , Especificidad de Órganos
8.
Clin Vaccine Immunol ; 16(10): 1485-92, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19675222

RESUMEN

Invasive aspergillosis is a significant cause of morbidity and mortality in patients after stem cell transplantation, in solid organ transplant recipients, and in patients with hematological malignancies. The interactions between human immature dendritic cells (iDCs) and Aspergillus fumigatus antigens are widely uncharacterized. We analyzed the immune response of iDCs to different recombinant A. fumigatus antigens (Aspf1 and Crf1). One of these antigens, the 18-kDa RNase Aspf1, triggered the increased level of expression of genes encoding proinflammatory cytokines and chemokines, and augmented the activation of NFkappaB and the apoptosis of iDCs. Furthermore, by fluorescence microscopy, we could demonstrate that in the first 3 h a major portion of Aspf1 accumulates on the cell surface. Finally, we could show an increased segregation of cytokines and chemokines after the stimulation of iDCs by an Aspf1 deletion mutant strain of A. fumigatus.


Asunto(s)
Alérgenos/inmunología , Aspergillus fumigatus/inmunología , Células Dendríticas/inmunología , Proteínas Fúngicas/inmunología , Alérgenos/administración & dosificación , Alérgenos/genética , Presentación de Antígeno , Antígenos Fúngicos/administración & dosificación , Antígenos Fúngicos/genética , Antígenos de Plantas , Apoptosis , Aspergilosis/etiología , Aspergilosis/inmunología , Aspergilosis/microbiología , Aspergillus fumigatus/genética , Aspergillus fumigatus/patogenicidad , Secuencia de Bases , Diferenciación Celular , Técnicas de Cocultivo , ADN de Hongos/genética , Células Dendríticas/citología , Proteínas Fúngicas/administración & dosificación , Proteínas Fúngicas/genética , Genes Fúngicos , Neoplasias Hematológicas/complicaciones , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Mutación , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Linfocitos T/inmunología , Trasplantes/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...